Now I understand
We are all part of the same experiment. A behavioural change experiment. To protect ourselves and the people around us against COVID-19 we have to change our behaviour. Social distancing, wearing face masks, disinfecting hands, no shaking hands, no hugging, etc. How do you experience this? Do you find it hard? Are you already used to this? No desire to 'get back to normal'? These measures have been proven to be effective and prevent us from getting sick with, or even worse dying of, COVID-19. They help us to stay healthy. But still, even though we know how we can protect ourselves against this disease, it is hard, very hard to constantly live with these measures. They don't come natural. At first, I did not mind so much. I was scared of getting COVID-19 and would do the necessary to stay safe. But over time it became harder to keep at a distance from family and friends. And now I am really looking forward to leaving 'this' all behind. And this makes it abundantly clear to me how difficult it is to combat malaria because it requires that people change their behaviour. And if these people also have a strong desire to get 'back to normal' then it is not difficult to understand why many of them choose not to sleep under a bednet. Even if these nets would protect them agains disease. Now I understand.
Stay healthy, stay safe and enjoy MalariaWorld
Founder & Senior Editor MalariaWorld
Director Dutch Malaria Foundation
COVID-19 has placed a strain on health systems globally. Last March 2020, APMEN held a session at an early stage in the pandemic, where we explored how countries in the Asia Pacific region were going about sustaining malaria services despite the nascent health crisis of COVID-19. A year on, as we are still very much dealing with the pandemic and rolling out the vaccine progressively, we take stock on the region’s ongoing challenges and successes in keeping malaria under check.
Watch below the recording of the MESA webinar "New Approaches to Improve Malaria Mosquito Surveillance and Control", featuring Fredros Okumu, director of science at the Ifakara Health Institute (IHI) in Tanzania, and Mercy Opiyo, medical entomologist at the Manhiça Health Research Centre (CISM) in Mozambique and the Barcelona Institute for Global Health (ISGlobal) in Spain.
ROCKVILLE, MD, USA - June 8, 2021 - The PfSPZ malaria vaccines of Sanaria Inc. are unique in vaccine development as they are composed of weakened (attenuated) forms of the live parasite cells that cause malaria. These parasite cells are called eukaryotic cells and there are no vaccines against any infectious disease composed of such cells. Furthermore, there are no licensed vaccines against any infectious disease caused by a eukaryotic pathogen.
World Health Organization, 28 May 2021
The World Health Assembly, the main governing body of the World Health Organization, has adopted a new resolution that aims to revitalize and accelerate efforts to end malaria, a preventable and treatable disease that continues to claim more than 400 000 lives annually.
Watch below the recording of the MasterClass "The Enduring Search for Malaria Vaccines" with Sanaria's Chief Executive and Scientific Officer Prof Stephen Hoffman.
Ifakara MasterClasses in Public Health Research & Practice. Episode XXV: Thursday, June 3rd 2021.
The remarkable discovery of considerable plasmodial life cycle activity in the human spleen has been reported [1,2]. There is also recent non-microscopic evidence suggestive of malaria parasite accumulation there .
The idea that the non-circulating parasite origin of Plasmodium vivax malarial recurrence is both hypnozoites [1,2] and merozoites (not hypnozoites only) dates from 2011 [3,4]. The history appears in Table 1 in . There is recent (and superb) evidence that my decade-old, bimodal recurrence hypothesis must be correct.
The second session of the monthly MESA Webinars: Science for Malaria Impact will be held on June 10 at 2 PM CAT (8 AM EDT, 8 PM SGT). Focusing on entomology, it will feature Fredros Okumu, director of science at the Ifakara Health Institute (IHI) in Tanzania, and Mercy Opiyo, medical entomologist at the Manhiça Health Research Centre (CISM) in Mozambique and the Barcelona Institute for Global Health (ISGlobal) in Spain.
Deadline: 30 May 2021 at 17:00
It is the intent of this RFP to secure competitive proposals from capable vendors to carry out the supply of personal protective equipment and other implementation materials to Malaria Consortium Nigeria.
Sanaria is a biotechnology company developing vaccines protective against malaria. Sanaria’s vaccines have proven highly protective against Plasmodium falciparum infection in humans. Sanaria's vaccines are intended to be used to prevent malaria in individuals and, in combination with other malaria control measures, to halt transmission of and eliminate malaria from communities.
The Malaria Eradication Scientific Alliance (MESA) is seeking three volunteers as MESA Correspondents to report from the EMBL Conference BioMalPar XVII - Biology and Pathology of the Malaria Parasite to be held virtually on May 25 - 27, 2021.
Innovator Awards are open to researchers who are developing healthcare innovations that could have a major and measurable impact on human health. Individuals and teams from not-for-profit organisations can apply. Organisations can be based anywhere in the world (apart from mainland China). Funded organisations must sign up to the Wellcome grant conditions. You can work in any scientific discipline, including a discipline outside life sciences.
The Global Malaria Programme is seeking public comments on the following preferred product characteristics (PPC) on indoor residual spraying products for malaria transmission control in areas with insecticide-resistant mosquito populations.
Interested parties may provide their comments to firstname.lastname@example.org by 15 May 2021.
For the draft for consultation see attached pdf.
Many countries in the Asia-Pacific region have achieved impressive reductions in malaria burden, but persistent residual malaria caused in large part by outdoor-biting vectors pose a serious challenge to malaria elimination objectives. Repellent methods to reduce vector contact with humans offer a tantalizing approach to reduce transmission, and several different methods varying from topical applications, impregnated clothing, space-repellents and others have been tested.
Protect vulnerable children against malaria
We are thrilled to announce our new exciting partnership project "Printed mosquito nets for Uganda"!
For the first time, MESA will virtually celebrate a series of monthly discussions, the MESA Webinars: Science for Malaria Impact. These webinars bring together the malaria community of innovators and showcase the work of malaria-endemic researchers. Starting in May, the virtual events will be held on the first Wednesday of each month and will feature two researchers. These one-hour sessions will cover a range of topics, from social sciences to entomology, through insecticide drug resistance, stratification and genomics.
When: First Wednesday of each month until December
Time: 8:00 am EDT - 2:00 pm CEST/CAT - 8:00 pm SGT
Since 2017, WHO has supported a group of 21 malaria-eliminating countries through a special initiative called the “E-2020”. This report charts their progress towards a common goal: eliminating malaria within the 2020 timeline. According to this report, 8 E-2020 member countries reported zero indigenous cases of malaria in 2020, a remarkable achievement in view of the ongoing global COVID-19 pandemic. Maintaining zero cases is a testament to their commitment to protect hard-won gains and keep the disease at bay.
For the pdf of the report see attachment.
The Malaria Eradication Scientific Alliance (MESA) is seeking volunteers as MESA Correspondents to report from the online MESA Webinars: Science for Malaria Impact. The webinars will be held every first Wednesday of the month starting in May until December and will last 1h starting at 2:00 pm CEST.
It [25 April] is World Malaria Day 2021 and we call on all stakeholders to draw the line against this disease, because all malaria cases and deaths are preventable. Although the WHO African Region accounts for virtually all 94% of global malaria cases and deaths, our countries have made progress in preventing both.
Waging a malaria elimination campaign without community support is like fighting a battle with one arm tied behind your back. We need the people who bear the brunt of malaria to understand what elimination program objectives are, and gain their help to identify, deliver and assess solutions likely to achieve these objectives.
Fight Malaria, 16 April 2021
How decoding the mosquito’s sense of smell could take the bite out of malaria. An interview with Professor Conor McMeniman of the Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health...
On 30 March SciDev.net published an article titled Research colonialism still plagues Africa. In summary it reads: "African researchers are suffering from power dynamics that favour global North collaborators"; and "While some initiatives are helping build local capacity, others undervalue African collaborators."
Ever since the inception of knowledge-based malaria control more than a century ago, vector control has been the primary strategy for combatting malaria. In recent decades, the focus has been on the use of Insecticide-Treated Nets (ITNs) and Indoor Residual Spraying (IRS) of insecticides. In Asia Pacific, much of the transmission occurs outdoors, and such outdoor transmission is a major driver of residual malaria.
Malaria Minute, 9 April 2021
Researchers detail the extent of antimalarial drug resistance around the world, considering its implications for the WHO's Global Technical Strategy for Malaria.
Listen tot this Podcast
Yesterday I was reading a very interesting Forum Interview from 1998 with Dr Mohyeddin A. Farid about malaria eradication, titled "The malaria campaign - why not eradication?" where malaria is discussed as a political disease. Dr Farid worked for the World Health Organization from 1949 until his retirement in 1972. Because malaria is intertwined with socioeconomic development he discussed malaria as a political disease and stated that "It is an explosive disease, not a silent one. When epidemics cause too much suffering, the people revolt and can bring about governmental changes...".
Bednets and Indoor Residual Spraying (IRS) have been the mainstay interventions against malaria in recent decades. Together, these tools have translated in dramatic reductions in global malaria cases. Many nations approaching the pre-elimination phase still have residual malaria, largely as a result of outdoor transmission.
Countries in the Asia Pacific region have done extremely well in achieving impressing levels of malaria reduction, but many still face the challenges of pernicious residual malaria. In Greater Mekong Subregion, much of this remaining malaria occurs within remote forested areas among forest-goers and mobile populations, where transmission happens outdoors. In these situations, bed nets and indoor spraying are not effective. Much has been published and debated on the subject but remains as intractable a challenge as ever. What to do about it?
A few weeks ago I noticed the announcement of a new conference: the WiM—the Women in Malaria conference. I thought "wow, that's quite something" and expected that it would be some sort of (follow up on the) Women in Vector Control Workshop that the Pan-African Mosquito Control Association (PAMCA) organised just prior to it's 2019 annual conference in Yaoundé, Cameroon. I was truly moved by what happened during that symposium.
The Asia Pacific Malaria Elimination Network (APMEN) Vector Control Working Group is hosting a series of vector-related webinars to keep the elimination momentum.
View the recordings of the APMEN Tech Talk "Sampling methods for adult malaria vectors" - recorded on 28 April 2020